NMI Natural and Medical Sciences Institute
Daniel Junker has not added Biography.
If you are Daniel Junker and would like to personalize this page please email our Author Liaison for assistance.
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nature immunology Jan, 2021 | Pubmed ID: 32999467
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.
Nature communications Feb, 2021 | Pubmed ID: 33608538
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic and SARS-CoV-2.
ACS infectious diseases Jun, 2021 | Pubmed ID: 33724771
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.
Nature communications May, 2021 | Pubmed ID: 34035301
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern.
EMBO reports Feb, 2022 | Pubmed ID: 34927793
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
Cell reports Dec, 2021 | Pubmed ID: 34932974
Robust and durable serological response following pediatric SARS-CoV-2 infection.
Nature communications Jan, 2022 | Pubmed ID: 35013206
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
Emerging infectious diseases Apr, 2022 | Pubmed ID: 35203113
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany.
Frontiers in immunology , 2022 | Pubmed ID: 35251012
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants.
Scientific reports May, 2022 | Pubmed ID: 35505068
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.
Frontiers in immunology , 2022 | Pubmed ID: 36275672
Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies.
BMC infectious diseases Nov, 2022 | Pubmed ID: 36396985
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations.
Scientific reports Nov, 2022 | Pubmed ID: 36400804
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유